National Lung Cancer Trial Network

USA

The National Lung Cancer Trial Network (NLCTN) is a collaborative clinical research network dedicated to improving outcomes for lung cancer patients through the design and execution of multi-institutional clinical trials. Bringing together leading cancer centers, investigators, and healthcare professionals across the country, NLCTN focuses on developing and testing innovative therapies, including targeted treatments and immunotherapies. The network emphasizes rigorous scientific evaluation and patient-centered research, aiming to accelerate the translation of laboratory discoveries into effective clinical care. By fostering collaboration and standardizing protocols, the NLCTN plays a vital role in advancing lung cancer treatment and increasing survival rates for patients nationwide.